Deurle, Belgium

Evelyn De Tavernier

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 6.2

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Sure, I'll compose the article about Evelyn De Tavernier based on the information provided.

Title: The Innovative Mind of Evelyn De Tavernier

Introduction: Inventor Evelyn De Tavernier, a talented individual hailing from Deurle, BE, has made significant contributions in the field of medicine and biotechnology, holding an impressive total of 3 patents to her name.

Latest Patents:

1. "Factor X binders enhancing FX activation" - Evelyn's groundbreaking application focuses on unique FX binding molecules, including antibodies and their fragments, designed to enhance the treatment of haemophilia.

2. "PcrV binding single variable domain antibodies" - Her inventive polypeptides, composed of two or more immunoglobulin single variable domains, demonstrate remarkable efficacy in inhibiting and neutralizing the PcrV protein.

Career Highlights: Evelyn De Tavernier has left a lasting impact through her work at esteemed companies such as Ablynx N.V. and Novo Nordisk A/S, where her innovative spirit and scientific expertise have shone brightly.

Collaborations: Throughout her remarkable career, Evelyn has collaborated with esteemed individuals in the field, including the likes of Ann Union and Bruno Dombrecht, who have shared in her vision of pushing the boundaries of scientific research and development.

Conclusion: Evelyn De Tavernier's pioneering work stands as a testament to her unwavering dedication to advancing the realm of medical innovation. Her inventive spirit and collaborative efforts have undoubtedly left an indelible mark on the world of biotechnology, inspiring generations to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…